Grifols (GRFS) Change in Inventory (2009 - 2020)
Grifols' (GRFS) quarterly Change in Inventory came in at -$82.4 million in Q1 2020, up 45.15% YoY from -$56.8 million in Q2 2019, and up 70.56% on a QoQ basis from -$280.1 million in Q4 2019.
Grifols (GRFS) Change in Inventory (2009 - 2020) Analysis & Trends
Grifols (GRFS) has 12 years of Change in Inventory data on file, last reported at -$82.4 million in Q1 2020.
- Quarterly Change in Inventory rose 45.15% year-over-year to -$82.4 million in Q1 2020, while the trailing twelve-month figure through Mar 2020 was -$305.9 million (down 187.56% YoY) and the FY2025 annual result came in at -$112.9 million, down 506.4% from the prior year.
- Change in Inventory improved to -$82.4 million in Q1 2020, from -$280.1 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $206.9 million in Q4 2018 to a low of -$301.5 million in Q3 2016.
- A 5-year average of -$54.9 million and a median of -$29.6 million in 2016 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2017 — Change in Inventory surged 530.79% — and 2018, when it tumbled 5685.14%.
- Tracing GRFS's Change in Inventory over 5 years: stood at -$29.6 million in 2016, then surged by 530.79% to $127.6 million in 2017, then soared by 62.12% to $206.9 million in 2018, then tumbled by 235.34% to -$280.1 million in 2019, then jumped by 70.56% to -$82.4 million in 2020.
- The last three Change in Inventory figures came in at -$82.4 million (Q1 2020), -$280.1 million (Q4 2019), and -$150.3 million (Q1 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 571.00 Mn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 143.00 Mn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | - |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 31.00 Mn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 145.00 Mn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | - |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Grifols | 5.45 Bn | 4.45 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -82.45 Mn |
| Mar 31, 2020 | -82.45 Mn |
| Dec 31, 2019 | -280.06 Mn |
| Dec 31, 2019 | -280.06 Mn |
| Mar 31, 2019 | -150.30 Mn |
| Mar 31, 2019 | -150.30 Mn |
| Dec 31, 2018 | 206.94 Mn |
| Dec 31, 2018 | 206.94 Mn |
| Jun 30, 2018 | -266.03 Mn |
| Jun 30, 2018 | -266.03 Mn |
| Mar 31, 2018 | 103.03 Mn |
| Mar 31, 2018 | 103.03 Mn |
| Dec 31, 2017 | 127.65 Mn |
| Dec 31, 2017 | 127.65 Mn |
| Jun 30, 2017 | 4.76 Mn |
| Jun 30, 2017 | 4.76 Mn |
| Mar 31, 2017 | 63.80 Mn |
| Mar 31, 2017 | 63.80 Mn |
| Dec 31, 2016 | -29.63 Mn |
| Dec 31, 2016 | -29.63 Mn |